Table 1:
Demographic and clinical characteristics of the vLRTI and No LRTI cohorts.
| vLRTI (n=40) | No LRTI (n=22) | P value* | |
|---|---|---|---|
| Female, n (%) | 18 (45.0%) | 11 (50.0%) | 0.79 |
| Age in years, median (IQR) | 0.9 (0.3 – 1.6) | 10.2 (1.1–14.9) | <0.01 |
| Race | 0.71 | ||
| White, n (%) | 26 (65.0%) | 14 (63.6%) | |
| Black/African American, n (%) | 6 (15.0%) | 6 (27.3%) | |
| Asian, n (%) | 1 (2.5%) | 1 (4.5%) | |
| Native Hawaiian/Pacific Islander, n (%) | 1 (2.5%) | 0 (0.0%) | |
| American Indian/Alaska Native, n (%) | 1 (2.5%) | 0 (0.0%) | |
| Unknown/Not Reported, n (%) | 5 (12.5%) | 1 (4.5%) | |
| Hispanic/Latino ethnicity, n (%) | 8 (20.0%) | 1 (4.5%) | 0.14 |
| Comorbidity, n (%) | 14 (35.0%) | 11 (50.0%) | 0.29 |
| Immunocompromise, n (%) | 1 (2.5%) | 0 (0.0%) | 0.99 |
| Admission category | <0.01 | ||
| Medical, n (%) | 40 (100%) | 14 (63.6%) | |
| Surgical, n (%) | 0 (0.0%) | 5 (22.7%) | |
| Trauma, n (%) | 0 (0.0%) | 3 (13.6%) | |
| Infiltrates on initial CXR, n (%) | 36 (90.0%) | 12 (54.5%) | <0.01 |
| ARDS, n (%) | 18 (45.0%) | 4 (18.0%) | 0.05 |
| Received antibiotics, n (%) | 14 (35.0%) | 8 (36.4%) | 0.99 |
| Ventilator days, median (IQR) | 6 (5.0–9.0) | 6 (5.0–8.0) | 0.85 |
| ICU length of stay in days, median (IQR) | 10 (8.0–16.5) | 9 (6.3–13.3) | 0.25 |
| Hospital length of stay in day, median (IQR) | 14 (10.5–19.5) | 16 (9.5–38.8) | 0.34 |
| Mortality, n (%) | 1 (2.5%) | 3 (13.6%) | 0.12 |
*
Wilcoxon rank sum test used for all continuous variables. Fisher’s exact test used for all categorical variables. IQR, interquartile range; ARDS, acute respiratory distress syndrome; ICU, intensive care unit.